MedPath

Cortisone acetate

Generic Name
Cortisone acetate
Drug Type
Small Molecule
Chemical Formula
C23H30O6
CAS Number
50-04-4
Unique Ingredient Identifier
883WKN7W8X

Overview

Cortisone acetate was first isolate in 1935 and became more widely researched in 1949. Since then, glucocorticoids such as cortisone acetate have been used to treat a number of inflammatory conditions such as endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, and gastrointestinal diseases and disorders. Cortisone acetate was granted FDA approval on 13 June 1950.

Background

Cortisone acetate was first isolate in 1935 and became more widely researched in 1949. Since then, glucocorticoids such as cortisone acetate have been used to treat a number of inflammatory conditions such as endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, and gastrointestinal diseases and disorders. Cortisone acetate was granted FDA approval on 13 June 1950.

Indication

Cortisone acetate is indicated to treat a wide variety of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, and gastrointestinal diseases and disorders.

Associated Conditions

  • Acute Gouty Arthritis
  • Acute Leukemia
  • Adrenocortical Hyperfunction
  • Adrenocortical Insufficiency
  • Allergic Conjunctivitis (AC)
  • Ankylosing Spondylitis (AS)
  • Aspiration Pneumonitis
  • Asthma
  • Atopic Dermatitis
  • Berylliosis
  • Bullous dermatitis herpetiformis
  • Bursitis
  • Chorioretinitis
  • Choroiditis
  • Congenital Adrenal Hyperplasia (CAH)
  • Congenital Hypoplastic Anemia
  • Contact Dermatitis
  • Cushing's Syndrome
  • Drug hypersensitivity reaction
  • Epicondylitis
  • Erythroblastopenia
  • Hypercalcemia of Malignancy
  • Immune Thrombocytopenia (ITP)
  • Inflammation
  • Iridocyclitis
  • Iritis
  • Keratitis
  • Loeffler's syndrome
  • Lymphoma
  • Meningitis caused by Mycobacterium Tuberculosis
  • Mycosis Fungoides (MF)
  • Ophthalmia, Sympathetic
  • Optic Neuritis
  • Pemphigus
  • Perennial Allergic Rhinitis (PAR)
  • Posttraumatic Osteoarthritis
  • Psoriatic Arthritis
  • Regional Enteritis
  • Rheumatoid Arthritis
  • Rheumatoid Arthritis, Juvenile
  • Rosacea
  • Seasonal Allergic Rhinitis
  • Secondary thrombocytopenia
  • Serum Sickness
  • Severe Seborrheic Dermatitis
  • Stevens-Johnson Syndrome
  • Synovitis
  • Systemic Lupus Erythematosus
  • Tenosynovitis
  • Trichinosis
  • Tuberculosis (TB)
  • Ulcerative Colitis
  • Uveitis
  • Acquired immune hemolytic anemia
  • Acute rheumatic carditis
  • Anterior eye segment inflammation
  • Exfoliative erythroderma
  • Non-suppurative Thyroiditis
  • Severe Psoriasis
  • Symptomatic Sarcoidosis
  • Varicella-zoster virus acute retinal necrosis

FDA Approved Products

Cortisone Acetate
Manufacturer:Chartwell RX, LLC
Route:ORAL
Strength:25 mg in 1 1
Approved: 2023/01/19
NDC:62135-173
Allergies
Manufacturer:King Bio Inc.
Route:ORAL
Strength:12 [hp_X] in 118 mL
Approved: 2025/05/02
NDC:57955-4809
Regional Allergies Southern U.S.
Manufacturer:King Bio Inc.
Route:ORAL
Strength:12 [hp_X] in 59 mL
Approved: 2025/05/20
NDC:57955-0762
Appetite and Weight with P.H.A.T.
Manufacturer:King Bio Inc.
Route:ORAL
Strength:10 [hp_X] in 59 mL
Approved: 2025/05/20
NDC:57955-2819

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath